Market closed

Organovo/$ONVO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Organovo

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

Ticker

$ONVO
Trading on

Industry

Biotechnology

Employees

14

Organovo Metrics

BasicAdvanced
$2.4M
-
-$9.78
0.45
-
$2.4M
0.45
$4.15
$1.58
0.715
0.404
149.176
291.209
-2,511.60%
-123.36%
-378.40%
17.225
6.51
6.51
-0.208
-49.59%
-62.34%
-17.23%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ONVO

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Organovo stock?

Organovo (ONVO) has a market cap of $2.4M as of April 16, 2025.

What is the P/E ratio for Organovo stock?

The price to earnings (P/E) ratio for Organovo (ONVO) stock is 0 as of April 16, 2025.

Does Organovo stock pay dividends?

No, Organovo (ONVO) stock does not pay dividends to its shareholders as of April 16, 2025.

When is the next Organovo dividend payment date?

Organovo (ONVO) stock does not pay dividends to its shareholders.

What is the beta indicator for Organovo?

Organovo (ONVO) has a beta rating of 0.45. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.